True LD - Search Results

1

The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy.

Mitsuyama H, Wallner K, Merrick G, Virgin J, Orio P, Montgomery B, True LD. Mitsuyama H, et al. Among authors: true ld. Am J Clin Oncol. 2007 Dec;30(6):597-600. doi: 10.1097/COC.0b013e318145b9ba. Am J Clin Oncol. 2007. PMID: 18091053

2

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, Donnelly BJ, Venner PM, Perez CA, Murray KJ, Doggett RS, True LD. Shipley WU, et al. Among authors: true ld. J Clin Oncol. 1998 Nov;16(11):3576-83. doi: 10.1200/JCO.1998.16.11.3576. J Clin Oncol. 1998. PMID: 9817278 Clinical Trial.

3

Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma.

Dattoli M, Wallner K, True L, Sorace R, Koval J, Cash J, Acosta R, Biswas M, Binder M, Sullivan B, Lastarria E, Kirwan N, Stein D. Dattoli M, et al. Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):853-6. doi: 10.1016/s0360-3016(99)00259-x. Int J Radiat Oncol Biol Phys. 1999. PMID: 10571189

4

Prostate brachytherapy in patients with prior evidence of prostatitis.

Aggarwal S, Wallner K, True LD, Russell K, Sutlief S, Blasko J, Ellis W. Aggarwal S, et al. Among authors: true ld. Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):867-9. doi: 10.1016/s0360-3016(99)00281-3. Int J Radiat Oncol Biol Phys. 1999. PMID: 10571191

5

Temporary PSA rises and repeat prostate biopsies after brachytherapy.

Smathers S, Wallner K, Sprouse J, True L. Smathers S, et al. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1207-11. doi: 10.1016/s0360-3016(01)01568-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11483330

6

Argon plasma coagulation for rectal bleeding after prostate brachytherapy.

Smith S, Wallner K, Dominitz JA, Han B, True L, Sutlief S, Billingsley K. Smith S, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):636-42. doi: 10.1016/s0360-3016(01)01704-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11597803

7

I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial.

Wallner K, Merrick G, True L, Cavanagh W, Simpson C, Butler W. Wallner K, et al. Cancer J. 2002 Jan-Feb;8(1):67-73. doi: 10.1097/00130404-200201000-00012. Cancer J. 2002. PMID: 11895205 Clinical Trial.

8

Preexisting histologic evidence of prostatitis is unrelated to postimplant urinary morbidity.

Hughes S, Wallner K, Merrick G, Miller S, True LD. Hughes S, et al. Among authors: true ld. Int J Cancer. 2001;96 Suppl:79-82. doi: 10.1002/ijc.10351. Int J Cancer. 2001. PMID: 11992389

9

Clinical correlates of high intraprostatic brachytherapy dose volumes.

Jones S, Wallner K, Merrick G, Corriveau J, Sutlief S, True L, Butler W. Jones S, et al. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):328-33. doi: 10.1016/s0360-3016(02)02741-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023136 Clinical Trial.

10

Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.

Dattoli M, Wallner K, True L, Cash J, Sorace R. Dattoli M, et al. Cancer. 2003 Feb 15;97(4):979-83. doi: 10.1002/cncr.11154. Cancer. 2003. PMID: 12569596 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters